CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-26 | Litchfield Caroline EVP & CFO | Grant or award | +15,852 | $107.40 | $1.7M | 90,192.19 |
| 2026-01-26 | Li Dean Y Executive VP & President, MRL | Grant or award | +20,469 | $107.40 | $2.2M | 102,270.05 |
| 2026-01-26 | Guindo Chirfi Chief Marketing Officer | Grant or award | +9,865 | $107.40 | $1.1M | 100,615.13 |
| 2026-01-26 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award | +12,264 | $107.40 | $1.3M | 197,858.83 |
| 2026-01-26 | Davis Robert M Chairman, CEO & President | Grant or award | +47,434 | $107.40 | $5.1M | 491,035.76 |
| 2026-01-26 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Grant or award | +13,880 | $107.40 | $1.5M | 13,880 |
| 2025-12-31 | Seidman Christine E Director | Grant or award · Phantom Stock | +77.19 | $105.26 | $8K | 19,025.67 |
| 2025-12-31 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +463.14 | $105.26 | $49K | 107,075.67 |
| 2025-12-31 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +285.01 | $105.26 | $30K | 29,231.57 |
| 2025-11-10 | Downing Cristal N Chief Comm. & Public Afrs Ofcr | Sale | −7,085 | $87.00 | $616K | 0 |
| 2025-11-03 | Williams David Michael EVP,Chief Info&Digital Officer | Sale | −8,614 | $83.59 | $720K | 24,578.03 |
| 2025-09-30 | Seidman Christine E Director | Grant or award · Phantom Stock | +96.81 | $83.93 | $8K | 18,775.78 |
| 2025-09-30 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +580.84 | $83.93 | $49K | 105,645.9 |
| 2025-09-30 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +357.44 | $83.93 | $30K | 28,684.66 |
| 2025-08-04 | Williams David Michael EVP,Chief Info&Digital Officer | Option exercise | +17,119 | $79.29 | $1.4M | 41,445.47 |
| 2025-08-04 | Williams David Michael EVP,Chief Info&Digital Officer | Shares withheld for taxes | −8,432 | $79.29 | $669K | 33,013.47 |
| 2025-08-04 | Williams David Michael EVP,Chief Info&Digital Officer | Option exercise · Restricted Stock Unit | −17,119 | 0 | ||
| 2025-08-04 | Guindo Chirfi Chief Marketing Officer | Option exercise | +36,903 | $79.29 | $2.9M | 107,408.97 |
| 2025-08-04 | Guindo Chirfi Chief Marketing Officer | Shares withheld for taxes | −18,175 | $79.29 | $1.4M | 89,233.97 |
| 2025-08-04 | Guindo Chirfi Chief Marketing Officer | Option exercise · Restricted Stock Unit | −36,903 | 0 |
Page 9 of 19 · 376 trades